title: Bronchiolitis obliterans organizing pneumonia in three children with acute leukaemias treated with cytosine arabinoside and anthracyclines.
abstract: Bronchiolitis obliterans organizing pneumonia (BOOP) is a clinicopathological entity with well-defined diagnostic criteria, which can be idiopathic or produced by a variety of biological processes. We describe the occurrence of BOOP in three children, one with acute lymphoblastic leukaemia and two with acute promyelocytic leukaemia. In the three patients, BOOP developed 10-20 days after a course of therapy with cytosine arabinoside and anthracyclines. The possible relationships between the small conducting airway lesions, lung toxic reaction to the drugs and/or nonidentified infectious agents are discussed.
authors.affiliation: Divisione di Pneumologia, Istituto G. Gaslini, Genoa, Italy.
authors.forename: E
authors.initials: E
authors.lastname: Battistini
authors.forename: G
authors.initials: G
authors.lastname: Dini
authors.forename: C
authors.initials: C
authors.lastname: Savioli
authors.forename: A
authors.initials: A
authors.lastname: Morando
authors.forename: A
authors.initials: A
authors.lastname: Gandolfo
authors.forename: Z
authors.initials: Z
authors.lastname: Kotitsa
authors.forename: A
authors.initials: A
authors.lastname: Garaventa
authors.forename: G A
authors.initials: GA
authors.lastname: Rossi
mesh_terms: D018943:Anthracyclines / Q000009:adverse effects / Q000627:therapeutic use; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use; D001982:Bronchial Diseases / Q000473:pathology; D002648:Child; D018549:Cryptogenic Organizing Pneumonia / Q000150:complications / Q000175:diagnosis* / Q000209:etiology*; D003561:Cytarabine / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000150:complications* / Q000188:drug therapy; D008168:Lung / Q000187:drug effects / Q000473:pathology; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications* / Q000188:drug therapy
chemical_list: D018943:Anthracyclines; D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine